Detalles de la búsqueda
1.
Evaluation of serious infections, including Mycobacterium tuberculosis, during treatment with biologic disease-modifying antirheumatic drugs: does line of therapy matter?
Rheumatology (Oxford)
; 2023 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37758229
2.
Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA.
Rheumatology (Oxford)
; 62(12): 3849-3857, 2023 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36943379
3.
Outcomes following switching from etanercept originator to etanercept biosimilar in 1024 RA patients: A matched-analysis of the BSRBR-RA.
Rheumatology (Oxford)
; 2023 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37672014
4.
Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Rheumatology (Oxford)
; 59(3): 559-567, 2020 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31722431
5.
Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Ann Rheum Dis
; 77(10): 1405-1412, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29980575
6.
Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Rheumatology (Oxford)
; 57(9): 1533-1540, 2018 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28968862
7.
Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Ann Rheum Dis
; 76(3): 497-503, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27502891
8.
Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis.
Ann Rheum Dis
; 76(4): 654-660, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28073800
9.
The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis.
Rheumatology (Oxford)
; 55(11): 2033-2039, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27550304
10.
Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
Ann Rheum Dis
; 74(6): 1087-93, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24685910
11.
The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA.
Ann Rheum Dis
; 73(1): 252-5, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23644671
12.
Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.
Ann Rheum Dis
; 72(2): 229-34, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22532633
13.
Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register.
Rheumatology (Oxford)
; 52(10): 1905-13, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23873820
14.
Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population.
Rheumatology (Oxford)
; 52(1): 91-8, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23238979
15.
Response to: 'Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?' by Nocturne et al.
Ann Rheum Dis
; 76(2): e4, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27934677
16.
The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register.
Ann Rheum Dis
; 71(6): 869-74, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22241900
17.
Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register.
Rheumatology (Oxford)
; 56(4): 672-673, 2017 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28003495
18.
Pregnancy outcomes in women with rheumatoid arthritis ever treated with rituximab.
Rheumatology (Oxford)
; 56(4): 661-663, 2017 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28137762
19.
Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register.
Ann Rheum Dis
; 70(5): 823-6, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21362710
20.
Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Ann Rheum Dis
; 70(4): 583-9, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21330639